HomeInsights52 Week High Stocks

Concord Drugs Ltd 52 Week High

Concord Drugs Ltd 52 Week High

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

0.6 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

YEARHIGH

₹ 61.5

Last updated on: Dec 11, 2024

Key Highlights

  • The 52 Week HIGH of Concord Drugs Ltd is ₹ 61.5 as of 11 Dec 24 .

Company Fundamentals for Concord Drugs Ltd

No data available

Market Price of Concord Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Concord Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 202436.87
10 Dec 202437.71
09 Dec 202437.98
06 Dec 202437.86
05 Dec 202438.01
04 Dec 202438.23
03 Dec 202437.34
02 Dec 202435
29 Nov 202435
28 Nov 202435.35

Asset Value vs Market Value of Concord Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Concord Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Drugs Ltd

No data available

* All values are in crore

Concord Drugs Ltd News Hub

News

Concord Drugs announces board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 November ...

Read more

08 Nov 2024 12:33

News

Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 2024 17:57

News

Concord Drugs schedules AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 2024 10:06

News

Concord Drugs fixes board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September ...

Read more

03 Sep 2024 11:10

News

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 202...

Read more

06 Aug 2024 16:20

News

Concord Drugs postpones board meeting

Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to b...

Read more

25 May 2024 11:26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Concord Drugs Ltd

What is the significance of Concord Drugs Ltd reaching its 52-week high?

Concord Drugs Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Concord Drugs Ltd 52-week high?

Investors monitor Concord Drugs Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Concord Drugs Ltd a good buy when it hits its 52-week high?

Whether Concord Drugs Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Concord Drugs Ltd fundamentals.

What should I consider before investing in Concord Drugs Ltd at its 52-week high?

Before investing in Concord Drugs Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Concord Drugs Ltd stock price continue to rise after reaching its 52-week high?

Concord Drugs Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions